Prostate cancer: from Gleason scoring to prognostic grade grouping

Expert Rev Anticancer Ther. 2016;16(4):433-40. doi: 10.1586/14737140.2016.1160780.

Abstract

The Gleason grading system was developed in the late 1960s by Dr. Donald F. Gleason. Due to changes in prostatic adenocarcinoma (PAC) detection and treatment, newer technologies to better characterize prostatic pathology, subsequently described variants of PAC and further data relating various morphologic patterns to prognosis, the application of the Gleason grading system changed substantially in surgical pathology. First in 2005 and more recently in 2014, consensus conferences were held to update PAC grading. Here, we review of the successive changes in the grading of PAC from the original system, with emphasis on the newest prognostic grade grouping.

Keywords: 2005 ISUP Gleason modified system; 2014 ISUP Gleason modified system; Gleason grading; International society of urological pathology; Prostate cancer; prognostic grade grouping.

Publication types

  • Review

MeSH terms

  • Adenocarcinoma / pathology
  • Consensus Development Conferences as Topic
  • Humans
  • Male
  • Neoplasm Grading / methods*
  • Prognosis
  • Prostatic Neoplasms / genetics
  • Prostatic Neoplasms / pathology*